Frexalimab Clinical Trials

4 actively recruiting trials across 3 locations

Also known as: SAR441344

Filter by location:

Birmingham, Alabama2 trials

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis

University of Alabama at Birmingham- Site Number : 8401135

Phase 3

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis

Alabama Neurology Associates- Site Number : 8400115

Phase 3

Homewood, Alabama1 trial

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

Alabama Neurology Associates- Site Number : 8400115

Phase 3

San Francisco, California1 trial

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

University of California San Francisco - Mission Bay- Site Number : 8400012

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.